$0.01
(1.47%)
Create an alert
Stocks and Shares ISAXtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. The Company's products serve the specialized needs of orthopedic and neurological surgeons, as well as trauma, foot and ankle, sports medicine, wound care surgeons including orthobiologics for the promotion of bone healing, amniotic tissue and collagen for both surgical repair and chronic wound care, implants and instrumentation for the treatment of spinal disease. Its orthobiologics products include OsteoSponge, OsteoSelect DBM Putty, OsteoSelect PLUS DBM Putty, 3Demin, OsteoFactor Pro, OsteoVive Plus, and nanOss. Its spinal implant product categories include cervical, thoracolumbar, sacroiliac joint, and interbody. The Company has exclusive United States distribution rights to Dilon's HEMOBLAST Bellows.
Company Information
About this company
Key people
Stavros G. Vizirgianakis
Independent Chairman of the Board
Sean E. Browne
President, Chief Executive Officer, Director
Scott C. Neils
Chief Financial Officer
Mark A. Schallenberger
Chief Operating Officer
Abhinav Jain
Director
Tyler P. Lipschultz
Director
John K. Bakewell
Independent Director
Jonn R. Beeson
Independent Director
Click to see more
Key facts
- Shares in issue140.07m
- EPICXTNT
- ISINUS98420P3082
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$74.07m
- Employees151
- ExchangeNyse American LLC
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.